98 related articles for article (PubMed ID: 25579512)
1. Regulatory mechanisms and clinical perspectives of miR-34a in cancer.
Li L
J Cancer Res Ther; 2014; 10(4):805-10. PubMed ID: 25579512
[TBL] [Abstract][Full Text] [Related]
2. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
3. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential.
Nie D; Fu J; Chen H; Cheng J; Fu J
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781524
[TBL] [Abstract][Full Text] [Related]
4. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
5. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
6. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Tong AW; Nemunaitis J
Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
[TBL] [Abstract][Full Text] [Related]
7. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
[TBL] [Abstract][Full Text] [Related]
9. The miR-34 family in cancer and apoptosis.
Hermeking H
Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.
Farooqi AA; Tabassum S; Ahmad A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036883
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia.
Wang X; Li J; Dong K; Lin F; Long M; Ouyang Y; Wei J; Chen X; Weng Y; He T; Zhang H
Cell Signal; 2015 Mar; 27(3):443-52. PubMed ID: 25499621
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
Li X; Zhao H; Zhou X; Song L
Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
18. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
Tokarz P; Blasiak J
Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
20. miR-214: a potential biomarker and therapeutic for different cancers.
Sharma T; Hamilton R; Mandal CC
Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
